OTC Analgesic Label Warnings Should Extend To Advertising, Committee Says
This article was originally published in The Tan Sheet
Executive Summary
FDA Nonprescription Drugs Advisory Committee-endorsed labeling changes for OTC analgesics should be reflected in all advertising and educational materials for the products, committee reps suggested